INDIAN BENCHMARK started on a negative note on the last day of the June series weighed down by weakness in oil & gas heavyweights as the government maintained status quo on gas prices for another three months.
FURTHER, Dr Reddy’s Laboratories announced that it launched Paricalcitol Capsules in the US market following approval from the United States Food & Drug Administration. Crompton Greaves along with the other consortium partners Fabricom and Iemants, has been selected by Van Oord, for the offshore wind project `Gemini' in the Netherlands.
Trend in FII flows: The FIIs were net buyers of Rs 192cr in the cash segment on Wednesday while the DIIs were net sellers of Rs. 433cr, as per the provisional figures released by the NSE.
For more details call us: 0731-6669900,6790000
Click here: capitalstars.com
FURTHER, Dr Reddy’s Laboratories announced that it launched Paricalcitol Capsules in the US market following approval from the United States Food & Drug Administration. Crompton Greaves along with the other consortium partners Fabricom and Iemants, has been selected by Van Oord, for the offshore wind project `Gemini' in the Netherlands.
Trend in FII flows: The FIIs were net buyers of Rs 192cr in the cash segment on Wednesday while the DIIs were net sellers of Rs. 433cr, as per the provisional figures released by the NSE.
For more details call us: 0731-6669900,6790000
Click here: capitalstars.com
The major gainers on the D-street included Sun Pharma, TCS, Wipro, Dr. Reddy.
ReplyDeletefree stock tips